Inhibitory effect of galantamine and donepezil combination against cholinesterase: An in silico and in vitro study
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202300581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Camila W Adarvez-Feresin und 6 weiteren Autor:innen. Beteiligte Einrichtung: IMIBIO-SL CONICET, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, San Luis, San Luis, Argentina. Hauptthemen laut MEDLINE: Galantamine, Alzheimer Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas, Agencia Nacional de Promoción Científica y Tecnológica.
Abstract (Originalsprache)
This study aimed to evaluate the in silico and in vitro inhibitory effect of the combined use of galantamine (GAL) and donepezil (DON) against acetylcholinesterase and butyrylcholinesterase (BuChE) enzymes. In silico and in vitro cholinesterase analysis were carried out for GAL and DON alone and combined. Molecular modeling studies were carried out (docking analysis, molecular dynamics simulation, and quantum theory of atoms in molecules). Cholinesterase's inhibitory activities by modified Ellman's method and the drug combination effect using the Chou–Talalay method were assayed. GAL/DON combination showed the co‐occupancy of the ligands in both enzymes through in silico studies. Regarding in vitro BuChE inhibition analyses, three of five combinations showed an interaction between GAL and DON at the threshold of additive affect (0.9 < CI < 1.1), with a tendency toward a synergistic effect for higher concentrations. This is the first report showing the efficacy of the GAL/DON combinations inhibiting BuChE, showing the importance of analyzing the behavior of different ligands when co‐occupancy into the active site is possible. These combinations might be a possible therapy to improved efficacy, reduced doses, minor side effects, and high levels of the neurotransmitter in the synaptic space for Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IMIBIO-SL CONICET, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, San Luis, San Luis, Argentina.
- Instituto de Biotecnología, Facultad de Ingeniería, Universidad Nacional de San Juan, San Juan, San Juan, Argentina.
ORCID-Profile: Camila W Adarvez-Feresin, Javier E Ortiz, Mauricio D Piñeiro, Oscar Parravicini, Ricardo D Enriz, Adriana D Garro
Förderung
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Agencia Nacional de Promoción Científica y Tecnológica
Zitieren
APA
Adarvez-Feresin, C. W., Ortiz, J. E., Piñeiro, M. D., Parravicini, O., Enriz, R. D., Garro, A. D., & Feresin, G. E. (2024). Inhibitory effect of galantamine and donepezil combination against cholinesterase: An in silico and in vitro study. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300581
Vancouver
Adarvez-Feresin CW, Ortiz JE, Piñeiro MD, Parravicini O, Enriz RD, Garro AD, et al. Inhibitory effect of galantamine and donepezil combination against cholinesterase: An in silico and in vitro study. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300581
BibTeX
@article{AdarvezFeresin2024,
author = {Adarvez-Feresin, Camila W and Ortiz, Javier E and Piñeiro, Mauricio D and Parravicini, Oscar and Enriz, Ricardo D and Garro, Adriana D and Feresin, Gabriela E},
title = {Inhibitory effect of galantamine and donepezil combination against cholinesterase: An in silico and in vitro study},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202300581}
}
EUVIMED